blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4248988

EP4248988 - ALKENYL SUBSTITUTED 2,5-PIPERAZINEDIONES AND THEIR USE IN COMPOSITIONS FOR DELIVERING AN AGENT TO A SUBJECT OR CELL [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  31.05.2024
Database last updated on 31.08.2024
FormerThe application has been published
Status updated on  25.08.2023
Most recent event   Tooltip28.06.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Massachusetts Institute of Technology
77 Massachusetts Avenue
Cambridge, MA 02139 / US
[2023/39]
Inventor(s)01 / ANDERSON, Daniel Griffith
Framingham, MA 01701 / US
02 / DORKIN, Joseph R.
Somerville, MA 02143 / US
03 / FENTON, Owen Shea
Somerville, MA 02143 / US
04 / KAUFFMAN, Kevin John
South Boston, MA 02127 / US
05 / MCCLELLAN, Rebecca L.
Westwood, MA 02090 / US
 [2023/39]
Representative(s)Crooks, Elizabeth Caroline, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[2023/39]
Application number, filing date23168103.217.06.2016
[2023/39]
Priority number, dateUS201562182264P19.06.2015         Original published format: US 201562182264 P
[2023/39]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP4248988
Date:27.09.2023
Language:EN
[2023/39]
Type: A3 Search report 
No.:EP4248988
Date:29.11.2023
Language:EN
[2023/48]
Search report(s)(Supplementary) European search report - dispatched on:EP27.10.2023
ClassificationIPC:C07D241/08
[2023/48]
CPC:
A61K38/1816 (EP,US); C07D241/08 (EP,CN,US); A61K48/0033 (US);
A61K31/4965 (CN); A61K47/545 (EP,US); A61P1/16 (EP,CN);
A61P11/00 (EP,CN); A61P19/00 (CN); A61P25/00 (EP,CN);
A61P29/00 (CN); A61P3/00 (EP,CN); A61P3/06 (EP);
A61P35/00 (EP,CN); A61P37/00 (CN); A61P37/06 (EP);
A61P7/00 (EP,CN); A61P7/04 (EP); A61P7/06 (EP) (-)
Former IPC [2023/39]A61K38/18
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/27]
Former [2023/39]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:ALKENYL SUBSTITUIERTE 2,5-PIPERAZINDIONE UND IHRE VERWENDUNG IN ZUSAMMENSETZUNGEN ZUR VERABREICHUNG EINES MITTELS AN EINE PERSON ODER IN EINE ZELLE[2023/39]
English:ALKENYL SUBSTITUTED 2,5-PIPERAZINEDIONES AND THEIR USE IN COMPOSITIONS FOR DELIVERING AN AGENT TO A SUBJECT OR CELL[2023/39]
French:PIPÉRAZINEDIONES SUBSTITUÉS PAR ALCÉNYLE ET LEUR UTILISATION DANS DES COMPOSITIONS POUR DÉLIVRER UN AGENT À UN SUJET OU DANS UNE CELLULE[2023/39]
Examination procedure28.05.2024Amendment by applicant (claims and/or description)
28.05.2024Examination requested  [2024/27]
28.05.2024Date on which the examining division has become responsible
Parent application(s)   TooltipEP16736955.2  / EP3310764
Fees paidRenewal fee
16.05.2023Renewal fee patent year 03
16.05.2023Renewal fee patent year 04
16.05.2023Renewal fee patent year 05
16.05.2023Renewal fee patent year 06
16.05.2023Renewal fee patent year 07
16.05.2023Renewal fee patent year 08
27.06.2024Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[AD]WO2013063468  (MASSACHUSETTS INST TECHNOLOGY [US]);
 [AD]WO2015061467  (SHIRE HUMAN GENETIC THERAPIES [US], et al);
by applicantUS4270537
 US4596556
 US4790824
 US4886499
 US4940460
 US4941880
 US5015235
 US5064413
 US5141496
 US5190521
 US5312335
 US5328483
 US5334144
 US5339163
 US5383851
 US5417662
 US5466220
 US5480381
 US5503627
 US5520639
 US5527288
 US5569189
 US5599302
 WO9713537
 US5649912
 WO9737705
 US5704911
 US5893397
 WO9934850
 US5993412
 WO0231025
 WO2004106411
 WO2006138380
 WO2007143659
 WO2008011561
 WO2010053572
 WO2013063468
 WO2014179562
 US2015140070
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.